NNNN
Income statement / Annual
Last year (2024), Anbio Biotechnology Class A Ordinary Shares's total revenue was $8.19 M,
an increase of 21.95% from the previous year.
In 2024, Anbio Biotechnology Class A Ordinary Shares's net income was $2.37 M.
See Anbio Biotechnology Class A Ordinary Shares,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$8.19 M |
$6.71 M |
$23.54 M |
$4.43 M |
| Cost of Revenue |
$2.30 M
|
$3.35 M
|
$10.98 M
|
$1.89 M
|
| Gross Profit |
$5.89 M
|
$3.36 M
|
$12.56 M
|
$2.54 M
|
| Gross Profit Ratio |
0.72
|
0.5
|
0.53
|
0.57
|
| Research and Development Expenses |
$454.23 K
|
$134.70 K
|
$200.00 K
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.44 M
|
$1.27 M
|
$2.17 M
|
$86.10 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.89 M
|
$1.40 M
|
$2.37 M
|
$86.10 K
|
| Cost And Expenses |
$6.19 M
|
$4.75 M
|
$13.35 M
|
$1.97 M
|
| Interest Income |
$337.51 K
|
$165.34 K
|
$42.25 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$8.00 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$13.04 K
|
$6.25 K
|
$0.00
|
| EBITDA |
$2.57 M |
$2.27 M |
$10.03 M |
$2.54 M |
| EBITDA Ratio |
0.31
|
0.34
|
0.43
|
0.57
|
| Operating Income Ratio |
0.24
|
0.29
|
0.43
|
0.55
|
| Total Other Income/Expenses Net |
$377.48 K
|
$292.78 K
|
-$184.41 K
|
$79.94 K
|
| Income Before Tax |
$2.37 M
|
$2.25 M
|
$10.01 M
|
$2.54 M
|
| Income Before Tax Ratio |
0.29
|
0.34
|
0.43
|
0.57
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
$2.37 M
|
$2.25 M
|
$10.01 M
|
$2.54 M
|
| Net Income Ratio |
0.29
|
0.34
|
0.43
|
0.57
|
| EPS |
0.056 |
0.0157 |
0.0696 |
0.0254 |
| EPS Diluted |
0.056 |
0.012 |
0.0696 |
0.0254 |
| Weighted Average Shares Out |
$42.29 M
|
$143.89 M
|
$143.89 M
|
$100.00 M
|
| Weighted Average Shares Out Diluted |
$42.29 M
|
$187.78 M
|
$143.89 M
|
$100.00 M
|
| Link |
|
|
|
|
